| Short Description : | PAX8 Blocking Peptide for STJ502169 is synthetically produced from the 170-220 sequence and is suitable for use in western blot applications. |
| Applications: | Immunodepletion/Immunocompetition |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Formulation: | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction: | Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
| Immunogen: | Synthetic peptide taken within amino acid region 170-220 on human PAX8 protein. |
| Immunogen Region: | 170-220 |
| Specificity: | This blocking peptide is recommended for use in combination with PAX8 antibody, STJ502169 |
| Background | Is a transcription factor for the thyroid specific expression of the genes expressed solely in the thyroid cell type. It maintains the funcitonal differentiation of cells such as those. |
Information sourced from Uniprot.org